U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07778628) titled 'WT1 in Colorectal Adenocarcinoma' on Aug. 18.
Brief Summary: Colorectal carcinoma is a major bublic health problem. It is due to several genetic mutations. Wilms' tumor1 (WT1) gene is a tumor suppressor gene that has been mutated in several human tumors. Detection of WT1 in colorectal carcinoma may provide better future results.
Study Start Date: Jan. 15, 2022
Study Type: OBSERVATIONAL
Condition:
Colorectal Cancer
Intervention:
BIOLOGICAL: immunohistochemical staining with WT1 antibody
4 micrometer thick tissue sections will be stained by anti humal WT1 immunohistochemical antibody.
Recruitment Status: COMPLETED
Sponsor: So...